AUA/SUFU Guideline on the Treatment of Overactive Bladder Allows Access to ReviTM System Earlier in Treatment Journey
The revised guidelines are a major affirmation of the importance of Revi as a therapy for patients with UUI.
- The revised guidelines are a major affirmation of the importance of Revi as a therapy for patients with UUI.
- First, the guidelines were updated to include iTNM as an acceptable minimally invasive therapy.
- "We are delighted to witness the transformation of the new OAB treatment guideline by the AUA/SUFU.
- This guideline represents a significant turning point in physicians' approach to OAB management," commented Dan Lemaitre, Chief Executive Officer of BlueWind Medical.